Capstone Holding Corp. (CAPS) is a construction materials company in the Basic materials sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Capstone Holding Corp. in 2026. The next earnings report is expected on November 6, 2026.
Next earnings date
06 Nov 2026
In 79 days
EPS estimate
0.19
Revenue estimate
24.6M
Past earnings
Latest earnings analysis
Capstone Holding Corp. met EPS estimates and exceeded revenue estimates in its latest earnings report, with EPS of $0.12 matching expectations and revenue of $21.5 million exceeding estimates by 5.5%. Both EPS and revenue also met expectations in the previous report.
No dividend history available.
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Capstone Holding Corp. (CAPS) is scheduled to report earnings on November 6, 2026.
Capstone Holding Corp. (CAPS) last reported earnings on August 12, 2026.
Capstone Holding Corp. (CAPS) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.